Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?
Voyager Therapeutics Ownership Summary
Voyager Therapeutics is owned by 28.89% institutional investors, 16.45% insiders, and 54.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.55% of VYGR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Voyager Therapeutics shares.
VYGR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Voyager Therapeutics | 28.89% | 16.45% | 54.66% |
| Sector | Healthcare Stocks | 232.51% | 10.72% | -143.23% |
| Industry | Biotech Stocks | 384.56% | 10.58% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 5.62M | 9.55% | $22.08M |
| Blackrock | 5.31M | 9.30% | $42.02M |
| Armistice capital | 4.20M | 7.16% | $19.61M |
| Vanguard group | 3.27M | 5.55% | $12.84M |
| Vestal point capital, lp | 1.48M | 2.51% | $6.89M |
| Erste asset management gmbh | 1.20M | 2.03% | $4.72M |
| Geode capital management | 1.14M | 1.93% | $4.46M |
| Dimensional fund advisors lp | 1.08M | 1.84% | $4.26M |
| State street | 925.36K | 1.58% | $4.32M |
| Ecor1 capital | 670.30K | 1.14% | $3.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Birchview capital, lp | 134.92K | 0.48% | $630.07K |
| Vestal point capital, lp | 1.48M | 0.31% | $6.89M |
| Armistice capital | 4.20M | 0.29% | $19.61M |
| Sphera funds management | 199.76K | 0.20% | $932.88K |
| Ecor1 capital | 670.30K | 0.15% | $3.13M |
| Clarivest asset management | 102.82K | 0.08% | $813.32K |
| Virtus fund advisers | 4.03K | 0.07% | $22.85K |
| Privium fund management b.v. | 95.00K | 0.07% | $373.35K |
| Caitong asset management | 5.94K | 0.06% | $23.36K |
| Patriot financial group insurance agency | 102.72K | 0.05% | $403.67K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 5.31M | 0.00% | 915.17K |
| Bank of america corp /de/ | 648.76K | 0.00% | 294.32K |
| Sphera funds management | 199.76K | 0.20% | 199.76K |
| Two sigma investments, lp | 140.72K | 0.00% | 140.72K |
| Birchview capital, lp | 134.92K | 0.48% | 134.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 670.30K | 0.15% | -3.25M |
| Farallon capital management | - | - | -715.00K |
| Great point partners | - | - | -626.27K |
| Armistice capital | 4.20M | 0.29% | -600.00K |
| Prudential financial | - | - | -330.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sphera funds management | 199.76K | 0.20% | 199.76K | $932.88K |
| Two sigma investments, lp | 140.72K | 0.00% | 140.72K | $657.14K |
| Birchview capital, lp | 134.92K | 0.48% | 134.92K | $630.07K |
| Two sigma advisers, lp | 58.60K | 0.00% | 58.60K | $273.66K |
| Cubist systematic strategies | 44.56K | 0.00% | 44.56K | $208.09K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Capital performance advisors llp | -16.00 |
| Richards, merrill & peterson | -30.00 |
| Rothschild investment | -30.00 |
| Gamma investing | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 78 | -34.45% | 16,989,289 | -43.76% | 28 | 1.09% | 30 | -43.40% | 29 | -25.64% |
| Sep 30, 2025 | 111 | -0.89% | 25,893,441 | -21.95% | 44 | 1.38% | 47 | 2.17% | 37 | 5.71% |
| Jun 30, 2025 | 109 | -6.03% | 33,129,261 | 7.64% | 56 | 2.03% | 45 | -2.17% | 33 | -21.43% |
| Mar 31, 2025 | 116 | -12.12% | 34,619,887 | 0.33% | 59 | 1.67% | 46 | -32.35% | 42 | 16.67% |
| Dec 31, 2024 | 131 | -0.76% | 34,504,533 | -1.80% | 59 | 1.62% | 67 | 15.52% | 36 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.71M | 3.10% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.68M | 3.02% | -36.97K |
| iShares Russell 2000 ETF | 1.14M | 2.06% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 474.33K | 0.86% | -193.13K |
| Fidelity Small Cap Index | 461.70K | 0.83% | -2.84K |
| Vanguard Explorer Inv | 457.06K | 0.83% | - |
| BlackRock Health Sciences Opps Inv A | 425.92K | 0.77% | - |
| iShares Russell 2000 Value ETF | 407.10K | 0.73% | - |
| T. Rowe Price Health Sciences | 346.56K | 0.62% | -3.89K |
| Federated Hermes MDT Small Cap Core IS | 270.35K | 0.50% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 10, 2026 | Swartz Robin | COO & CBO | Sell | $17.59K |
| Feb 10, 2026 | Sandrock Alfred | President and CEO | Sell | $46.09K |
| Feb 10, 2026 | Carter Todd Alfred | Chief Scientific Officer | Sell | $13.57K |
| Oct 03, 2025 | Jorgensen Nathan D. | Chief Financial Officer | Sell | $36.64K |
| Aug 18, 2025 | Ferguson Toby | Chief Medical Officer | Sell | $70.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 9 |
VYGR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools